The Long-term Efficacy of Domiciliary Noninvasive Positive-Pressure Ventilation in Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Controlled Trials

• Published in: Tuberculosis and respiratory diseases 2022-01, Vol.85 (1), p.47-55
• Main Authors: Park, So Young, Yoo, Kwang Ha, Park, Yong Bum, Rhee, Chin Kook, Park, Jinkyeong, Park, Hye Yun, Hwang, Yong Il, Park, Dong Ah, Sim, Yun Su
• Format: Article
• Language: Korean
• Subjects: Chronic Obstructive Pulmonary Disease; Mortality; Noninvasive Positive-Pressure Ventilation
• ISSN: 1738-3536; 2005-6184

Background: We evaluated the long-term effects of domiciliary noninvasive positive-pressure ventilation (NIPPV) used to treat patients with chronic obstructive pulmonary disease (COPD). Methods: Databases were searched to identify randomized controlled trials of COPD with NIPPV for longer than 1 year. Mortality rates were the primary outcome in this meta-analysis. The eight trials included in this study comprised data from 913 patients. Results: The mortality rates for the NIPPV and control groups were 29% (118/414) and 36% (151/419), suggesting a statistically significant difference (risk ratio [RR], 0.79; 95% confidence interval [CI], 0.65-0.95). Mortality rates were reduced with NIPPV in four trials that included stable COPD patients. There was no difference in admission, acute exacerbation and quality of life between the NIPPV and control groups. There was no significant difference in withdrawal rates between the two groups (RR, 0.99; 95% CI, 0.72-1.36; p=0.94). Conclusion: Maintaining long-term nocturnal NIPPV for more than 1 year, especially in patients with stable COPD, decreased the mortality rate, without increasing the withdrawal rate compared with long-term oxygen treatment.